Log in to save to my catalogue

Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic ca...

Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2577744310

Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study

About this item

Full title

Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study

Publisher

Dordrecht: Springer Netherlands

Journal title

Molecular biology reports, 2020-10, Vol.47 (10), p.8235-8241

Language

English

Formats

Publication information

Publisher

Dordrecht: Springer Netherlands

More information

Scope and Contents

Contents

Pancreatic adenocarcinoma (PDAC) is the most frequent histological type of malignancy in the pancreas. Extracellular matrix (ECM), plays a critical role during the process of human carcinogenesis and the possible diversity in matricellular proteins composition of ECM may have a significant impact on the clinical course of PDAC. Aim of this paper wa...

Alternative Titles

Full title

Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2577744310

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2577744310

Other Identifiers

ISSN

0301-4851

E-ISSN

1573-4978

DOI

10.1007/s11033-020-05763-2

How to access this item